Definitive Contract 75N93024C00085
Award Date
9/30/24
Potential Completion Date
9/29/25
Potential Value
$6M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Worcester, MA 01605, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,325,163.04 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMMS) for a project titled "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract does not have a set-aside designation. The objective is to conduct research to identify T-cell epitopes of pathogenic fungi including Blastomyces, Coccidioides, Cryptococcus, and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, worth a guaranteed minimum of $50,000.00, was awarded to the University of Massachusetts Medical School (UMass Medical) to provide animal models of infectious diseases research under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery vehicle (IDV). The contract is a firm...
This is a $7,839,205 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University. The contract supports research related to the discovery and validation of novel human B cell epitopes that elicit antibodies associated with infectious agents, autoimmune diseases, allergic conditions, and transplant rejection/tolerance. The contract is a definitive, cost-no-fee contract with a period of...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMass Medical) for the purchase of a 7 mg vial of the CD3 immunotoxin PR-0307 at a firm fixed price of $7,000.00. The award has no set-aside designation and was made as a purchase order on August 5, 2014, with a completion date of September 3, 2014. UMass Medical, which operates as a...
This definitive federal contract was awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to the La Jolla Institute for Immunology, a non-profit research organization, to conduct large-scale T cell epitope discovery research. The contract has a potential value of $4,499,760.00 and is not set aside for any specific business type. The contract involves multiple subcontractors to assist with the research, including the Universidad Peruana...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the Regents of the University of Michigan (UM) to provide research and development services for the project "IDENTIFYING TARGETS FOR THERAPEUTICS USING PROTEOMICS TECHNOLOGY". The contract was awarded on June 30, 2004 with a ceiling value of $5,968,614.00 and a completion date of June 29, 2009. The contract does not have a set-aside designation. As...
This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation. The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune...
This is a $5,455,392.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute. The contract is for the identification and validation of epitopes (immune system targets) that are conserved across viral pathogen families with pandemic potential. The research will focus on infectious diseases, autoimmune diseases, and transplant rejection. No set-aside was used for this award. The...
This is a $36,549,202.01 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for the Immune Epitope and Analysis Program. The contract has no set-aside designation and is set to run until December 14, 2025. As the prime contractor, the La Jolla Institute for Immunology is responsible for the overall program, which involves conducting research and providing services related to...
This federal contract award, valued at $5,403,317.00, was granted to the University of Washington (UW) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for the project "PROTECTIVE T CELL EPITOPES AND IMMUNE RECEPTORS FOR SEXUALLY TRANSMITTED INFECTIONS" and does not have a set-aside designation. The original solicitation indicates...